Plain-English translation of NCT04892654 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether you can switch from a three-medicine HIV regimen to a simpler two-medicine regimen using and while keeping your viral load undetectable. The study will compare two groups: one that switches to the medication right away, and one that waits 48 weeks before switching. Researchers will check your viral load regularly and ask about your overall health and quality of life throughout the study.
Many people with HIV do well on three medicines, but taking fewer pills each day could make treatment simpler and easier to stick with. This trial wants to find out if this two-medicine combination works just as well for people whose HIV is already well-controlled.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to either switch to the new two-medicine regimen right away or continue your current three-medicine regimen for 48 weeks before switching. Either way, you'll take the two-medicine combination for at least 48 weeks and up to 96 weeks total. You'll have regular study visits where your viral load will be checked, and you'll provide blood and urine samples and answer questionnaires about your health and quality of life every 24 weeks.
AI-generated summary from trial data · Jun 23, 2026 · Not medical advice
United Kingdom